Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature

C White, RJ Scott, C Paul, A Ziolkowski… - Pharmacogenomics …, 2021 - Taylor & Francis
Pharmacogenomic screening can identify patients with gene variants that predispose them
to the development of severe toxicity from fluoropyrimidine (FP) chemotherapy. Deficiency of …
被引用次数：31 相关文章

Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature

C White, RJ Scott, C Paul, A Ziolkowski… - Pharmacogenomics …, 2021 - dovepress.com
Pharmacogenomic screening can identify patients with gene variants that predispose them
to the development of severe toxicity from fluoropyrimidine (FP) chemotherapy. Deficiency of …
[HTML] nih.gov

[HTML][HTML] Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature

C White, RJ Scott, C Paul, A Ziolkowski… - Pharmacogenomics …, 2021 - ncbi.nlm.nih.gov
Pharmacogenomic screening can identify patients with gene variants that predispose them
to the development of severe toxicity from fluoropyrimidine (FP) chemotherapy. Deficiency of …

Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature.

C White, RJ Scott, C Paul, A Ziolkowski… - Pharmacogenomics …, 2021 - europepmc.org
Pharmacogenomic screening can identify patients with gene variants that predispose them
to the development of severe toxicity from fluoropyrimidine (FP) chemotherapy. Deficiency of …

Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature.

C White, RJ Scott, C Paul, A Ziolkowski… - Pharmacogenomics …, 2021 - go.gale.com
Pharmacogenomic screening can identify patients with gene variants that predispose them
to the development of severe toxicity from fluoropyrimidine (FP) chemotherapy. Deficiency of …

Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature

C White, RJ Scott, C Paul… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Pharmacogenomic screening can identify patients with gene variants that predispose them
to the development of severe toxicity from fluoropyrimidine (FP) chemotherapy. Deficiency of …

Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature

C White, RJ Scott, C Paul, A Ziolkowski… - Pharmacogenomics …, 2021 - search.proquest.com
Pharmacogenomic screening can identify patients with gene variants that predispose them
to the development of severe toxicity from fluoropyrimidine (FP) chemotherapy. Deficiency of …

Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature

C White, RJ Scott, C Paul, A Ziolkowski… - Pharmacogenomics …, 2021 - dovepress.com
Pharmacogenomic screening can identify patients with gene variants that predispose them
to the development of severe toxicity from fluoropyrimidine (FP) chemotherapy. Deficiency of …